Navigation Links
AMT's Marketing Authorisation Application for Glybera(R) Progressing on Schedule
Date:8/17/2010

se for which no treatment exists today. The disease is caused by mutations in the LPL gene, resulting in highly decreased or absent activity of LPL protein in patients. This protein is needed in order to break down large fat-carrying particles that circulate in the blood after each meal. When such particles, called chylomicrons, accumulate in the blood, they may obstruct small blood vessels. This can result not only in potentially lethal pancreatitis, but also in difficult-to-treat diabetes, and is associated with significant morbidity and mortality.

About Amsterdam Molecular Therapeutics

AMT is a leader in the development of human gene based therapies. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. This proprietary platform can be applied to a large number of rare (orphan) diseases that are caused by one faulty gene. Currently, AMT has a product pipeline with several AAV-based gene therapy products in LPLD, Hemophilia B, Duchenne Muscular Dystrophy, Acute Intermittent Porphyria, and, Parkinson's Disease at different stages of research or development. AMT was founded in 1998 and is based in Amsterdam.

-------------------------------------------------------------------------

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds Effective Social Media Marketing Strategies for Pharmaceutical Market
2. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
3. grey healthcare group (ghg) Expands Global Footprint with the Acquisition of Geoff Howe Marketing Communications
4. InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
5. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
6. International Drug & Explosives Detection Company Identa Corp Reports on New USA Marketing Representative
7. Effective Social Media Marketing Strategies for Pharmaceutical Market (2010 - 2015): MarketsandMarkets
8. Robotic Surgery: Medicine or Marketing?
9. CSL Behring Announces Completion of National Marketing Authorizations of Berinert® After MRP in 23 European Countries
10. HCD Research Executive Urges Pharmaceutical Industry to Leverage Social Media to Enhance Traditional Marketing Research
11. Stryker Enters Strategic Marketing Agreement with Acuitec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  Neuralstem, Inc. (NYSE ... , MD, PhD, principal investigator, presented updated Phase ... cell (NSI-566) trial in the treatment of amyotrophic lateral ... disease) at the neuro diabetes special medical symposium in ... a talk called "Recent Therapeutic Advances in Stem Cell ...
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/20/2013)... 20, 2013 With herbal medicines relied upon ... the U.S. Pharmacopeial Convention (USP) will provide freely available ... herbal ingredients used in these products. Today, USP proposes ... new Herbal Medicines Compendium ( HMC ) ... hmc.usp.org . HMC will provide ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
(Date:5/20/2013)... When people have lap ... become a celebrity. New Jersey governor Chris Christie, ... report (“Chris Christie Says Lap Band Surgery Is ... surgery was not done so that he could ... as a former lap band patient. Simply put, ...
(Date:5/20/2013)... Fountain Valley, CA (PRWEB) May 20, 2013 ... few dental professionals certified and trained to use the ... surgery designed to treat patients with gum disease. ... already lost teeth due to gum disease restore the ... disease begins with the buildup of plaque and tartar ...
(Date:5/20/2013)... 20, 2013 Mombo from Comfort ... conference of the US Lactation Consultant Association (USLCA) May ... nurses, doctors and other health professionals. , The ... helping lactation professionals discover and learn about the latest ... the most popular nursing pillows, which new mothers use ...
(Date:5/20/2013)... According to a May 6, 2013 CBS News article, ... tanning salons in the US may soon have to ... to see cancer warnings on indoor tanning beds ... for the use of indoor tanning and sun beds. The ... increasingly common over the last few decades (Go to goo.gl/TCT6m). ...
(Date:5/20/2013)... According to a June 2009 Bloomberg article, it ... to approximately $3.6 billion dollars per year (i). ... that there 15 million incidents of medical harm each ... who receives any form of medical treatment should be ... defines malpractice as “a dereliction of professional duty or ...
Breaking Medicine News(10 mins):Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Fountain Valley, Ca Gum Disease Patients with Missing Teeth Can Now Receive Laser Gum Surgery from Dr. Robert Mokbel for Success with Dental Implants 2Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:Law Firm Releases New Informational Graphic on the Basics of Understanding Medical Malpractice Cases 2
... /PRNewswire-Asia/ -- China Medicine Corporation,(OTC Bulletin Board: ... developer,and leading distributor of prescription and over-the-counter ... devices, and medical formulations in the People,s ... its Annual Meeting of Shareholders (the,AMS,) on ...
... tastes, sexual stimuli may also key personality disorders , , ... brain that process pleasurable experiences such as sweet tastes ... whether an individual is a "people person," say European ... brains of 41 males who,d completed a questionnaire designed ...
... to do so, study finds , , WEDNESDAY, May 20 (HealthDay ... healthfully or boost physical activity can significantly improve health habits, ... e-mail program walked more, ate more fruits and vegetables and ... didn,t receive the e-mails, according to a report in the ...
... Distinction" to its Dispensing Safety CredentialsATLANTA, May ... today it has granted the first-ever GREENGUARD ... equipment to Parata(R) Systems. Parata RDS is ... to receive this important designation. (Logo: ...
... now has a relevant interest in more than 50 ... Inc. (Nasdaq: CEPH ) announced today that ... now has a relevant interest in 50.1 percent of ... Offer for the company free from all outstanding conditions. ...
... moderate COPD were randomized to receive "usual care" ... that offered an intensive lifestyle moderation phase of ... detail to perform two 15-minute intervals of pleasurable ... lifestyle changes such as nutrition and smoking cessation. ...
Cached Medicine News:Health News:China Medicine Corporation Holds Annual General Meeting of Shareholders 2Health News:Being a 'People Person' May Be All in Your Head 2Health News:E-Mailing Your Way to Healthier Habits 2Health News:E-Mailing Your Way to Healthier Habits 3Health News:Parata Earns Pharmacy Industry's First-Ever GREENGUARD Certification for Indoor Air Quality 2Health News:Parata Earns Pharmacy Industry's First-Ever GREENGUARD Certification for Indoor Air Quality 3Health News:Parata Earns Pharmacy Industry's First-Ever GREENGUARD Certification for Indoor Air Quality 4Health News:Cephalon Acquires Controlling Interest in Arana Therapeutics 2Health News:Cephalon Acquires Controlling Interest in Arana Therapeutics 3Health News:Cephalon Acquires Controlling Interest in Arana Therapeutics 4Health News:Lifestyle program for patients with COPD is health and cost effective 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: